These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9760134)

  • 1. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets.
    Kanda T; Tashiro T; Kuwana Y; Jenner P
    Neuroreport; 1998 Aug; 9(12):2857-60. PubMed ID: 9760134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
    Shiozaki S; Ichikawa S; Nakamura J; Kitamura S; Yamada K; Kuwana Y
    Psychopharmacology (Berl); 1999 Nov; 147(1):90-5. PubMed ID: 10591873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys.
    Kanda T; Jackson MJ; Smith LA; Pearce RK; Nakamura J; Kase H; Kuwana Y; Jenner P
    Exp Neurol; 2000 Apr; 162(2):321-7. PubMed ID: 10739638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys.
    Kanda T; Jackson MJ; Smith LA; Pearce RK; Nakamura J; Kase H; Kuwana Y; Jenner P
    Ann Neurol; 1998 Apr; 43(4):507-13. PubMed ID: 9546333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.
    Grondin R; Bédard PJ; Hadj Tahar A; Grégoire L; Mori A; Kase H
    Neurology; 1999 May; 52(8):1673-7. PubMed ID: 10331698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
    Aoyama S; Kase H; Borrelli E
    J Neurosci; 2000 Aug; 20(15):5848-52. PubMed ID: 10908627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.
    Uchida S; Soshiroda K; Okita E; Kawai-Uchida M; Mori A; Jenner P; Kanda T
    Eur J Pharmacol; 2015 Jan; 747():160-5. PubMed ID: 25499739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats.
    Koga K; Kurokawa M; Ochi M; Nakamura J; Kuwana Y
    Eur J Pharmacol; 2000 Nov; 408(3):249-55. PubMed ID: 11090641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.
    Petzer JP; Steyn S; Castagnoli KP; Chen JF; Schwarzschild MA; Van der Schyf CJ; Castagnoli N
    Bioorg Med Chem; 2003 Apr; 11(7):1299-310. PubMed ID: 12628657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of adenosine A2A receptor in sleep promotion.
    Satoh S; Matsumura H; Hayaishi O
    Eur J Pharmacol; 1998 Jun; 351(2):155-62. PubMed ID: 9686998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-parkinsonian activity of the adenosine A
    Ohno Y; Okita E; Kawai-Uchida M; Fukuda N; Shoukei Y; Soshiroda K; Yamada K; Kanda T; Uchida S
    Eur J Pharmacol; 2023 Jul; 950():175773. PubMed ID: 37146707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats.
    Satoh S; Matsumura H; Suzuki F; Hayaishi O
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5980-4. PubMed ID: 8650205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adenosine A2a receptors in the nucleus accumbens.
    Barraco RA; Martens KA; Parizon M; Normile HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):545-53. PubMed ID: 8078988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
    J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
    Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K
    Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
    Chen JF; Moratalla R; Impagnatiello F; Grandy DK; Cuellar B; Rubinstein M; Beilstein MA; Hackett E; Fink JS; Low MJ; Ongini E; Schwarzschild MA
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1970-5. PubMed ID: 11172060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
    Chen JF; Xu K; Petzer JP; Staal R; Xu YH; Beilstein M; Sonsalla PK; Castagnoli K; Castagnoli N; Schwarzschild MA
    J Neurosci; 2001 May; 21(10):RC143. PubMed ID: 11319241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization by chronic diazepam treatment of A2A adenosine receptor-mediated relaxation in rat pulmonary artery.
    Ujfalusi A; Cseppentö A; Nagy E; Szabó JZ; Kovács P; Szentmiklósi AJ
    Life Sci; 1999; 64(2):PL19-25. PubMed ID: 10069495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.